510(k) Report

FDA product code · Clinical chemistry

Alternate Controller Enabled Insulin Infusion Pump

QFGClass II21 CFR 880.5730510(k) required30 decisions since 201913 recalls

30 FDA decisions since 2019. 510(k) reviews decided 2021–2025 took a median of 98 days (half between 44 and 266). 13 recalls name this code, 3 of them Class I. The most-cited predicate is K191679, named by 4 later devices.

An alternate controller enabled insulin infusion pump (ACE insulin pump) is a device intended for the infusion of insulin into a patient. The ACE insulin pump may include basal and bolus drug delivery at set or variable rates. ACE insulin pumps are designed to reliably and securely communicate with external devices, such as automated insulin dosing systems, to allow insulin delivery commands to be received…

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, clinical chemistry panel

Twenty years of QFG at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · QFG

5in 2025

2019: 22020: 12022: 22023: 92024: 52025: 52026 (partial year): 6
2007high 9 (2023) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QFG

44in 2025

2023: 150 days median2024: 89 days median2025: 44 days median2026 (partial year): 103 days median
2007high 150 (2023) · low 44 (2025)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QFG

8so far in 2026, the most since 2007

2022: 12023: 1, 1 Class I2025: 3, 1 Class I2026 (partial year): 8, 1 Class I
2007high 8 (2026) · low 0 (2007)2026

Class I (3 since 2007) Class II/III not classified

Adverse event reports per year · QFG

324,360in 2025

2020: 30,5222021: 74,7012022: 129,1192023: 188,0142024: 273,1802025: 324,360
2007high 324,360 (2025) · low 0 (2007)2025

MAUDE reports naming product code QFG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20192—00
20201—030,522
20210—074,701
20222—1129,119
202391501 (1)188,014
20245890273,180
20255443 (1)324,360
202661038 (1)—
FIG. 1 — QFG by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in QFG? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report